Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

DOUGLASS DAVID L — TRANS1 INC insider: 2 transactions · InsiderLens

Home / Insiders / DOUGLASS DAVID L

DOUGLASS DAVID L

10% owner at TRANS1 INC · on record since Mar 6, 2009
10% owner at Neutral Tandem Inc · on record since Nov 21, 2013
10% owner at NeuroMetrix, Inc. · on record since Jul 21, 2004
10% owner at TriVascular Technologies, Inc. · on record since Apr 24, 2014
10% owner at ALDER BIOPHARMACEUTICALS INC · on record since May 15, 2014
10% owner at Calithera Biosciences, Inc. · on record since Oct 9, 2014
10% owner at SENTEX SENSING TECHNOLOGY INC · on record since Mar 23, 2016

Insider trading activity of DOUGLASS DAVID L

Transactions on record: 2; since Mar 3, 2009

Open-market buys: 2; $295K

Open-market sells: 0

Companies traded: 1; last filing Mar 3, 2009

Figures computed from official regulatory filings — methodology.

Companies where DOUGLASS DAVID L has traded

TRANS1 INC2 tx · $295K · Mar 3, 2009

Track record of DOUGLASS DAVID L

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of DOUGLASS DAVID L

Co-insiders of DOUGLASS DAVID L

BOCHNOWSKI JAMES JALDER BIOPHARMACEUTICALS INC +6
PAKIANATHAN DEEPIKAALDER BIOPHARMACEUTICALS INC +5
ROEDER DOUGLAS AALDER BIOPHARMACEUTICALS INC +5
Delphi BioInvestments VIII LPCalithera Biosciences, Inc. +4
Delphi Management Partners VIII, L.L.C.Calithera Biosciences, Inc. +4
DELPHI VENTURES VIII LPCalithera Biosciences, Inc. +4
BARRETT M JAMESNeutral Tandem Inc +2

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

BARRIS PETER JNeutral Tandem Inc +2

SANDELL SCOTT DNeutral Tandem Inc +2

BONDERMAN DAVIDALDER BIOPHARMACEUTICALS INC +1

COULTER JAMES GALDER BIOPHARMACEUTICALS INC +1

DELPHI BIOINVESTMENTS VII LPALDER BIOPHARMACEUTICALS INC +1

Delphi Management Partners VII, L.L.C.ALDER BIOPHARMACEUTICALS INC +1

DELPHI VENTURES VII L PALDER BIOPHARMACEUTICALS INC +1

HANSEN BRIAN BNeutral Tandem Inc +1

NEA PARTNERS 10 L PNeutral Tandem Inc +1

NEW ENTERPRISE ASSOCIATES 10 L PNeutral Tandem Inc +1

TPG Group Holdings (SBS) Advisors, Inc.ALDER BIOPHARMACEUTICALS INC +1

Abkemeier KurtNeutral Tandem Inc

Adage Capital Advisors, L.L.C.Calithera Biosciences, Inc.

ADAGE CAPITAL PARTNERS GP LLCCalithera Biosciences, Inc.

ADAGE CAPITAL PARTNERS LPCalithera Biosciences, Inc.

Advanced Technology Ventures VII(B), L.P.TRANS1 INC

Advanced Technology Ventures VII(C), L.P.TRANS1 INC

Advanced Technology Ventures VIII LPCalithera Biosciences, Inc.

ADVANCED TECHNOLOGY VENTURES VII LPTRANS1 INC

AGARWAL SUNILCalithera Biosciences, Inc.

Ainsworth Stephen DTRANS1 INC

Alessi NicholasNeuroMetrix, Inc.

Allen DickNeutral Tandem Inc

Anacone RobertNeutral Tandem Inc

ANDRIES BRANDONTRANS1 INC

ANHALT HENRYNeutral Tandem Inc

Assell Robert L.TRANS1 INC

Atchinson RobertCalithera Biosciences, Inc.

ATV Alliance 2002, L.P.TRANS1 INC

ATV Alliance Associates, L.L.C.TRANS1 INC

ATV Associates VIII, L.L.C.Calithera Biosciences, Inc.

ATV Associates VII, L.L.C.TRANS1 INC

ATV Entrepreneurs VII, L.P.TRANS1 INC

Azelby RobertALDER BIOPHARMACEUTICALS INC

Balachandran KrishnamurthyNeuroMetrix, Inc.

BancBoston Ventures, Inc.NeuroMetrix, Inc.

BANK OF AMERICA CORP /DE/NeuroMetrix, Inc.

BASKETT FORESTTriVascular Technologies, Inc.

BAYLESS JON WALDER BIOPHARMACEUTICALS INC

Beatty JosephNeutral Tandem Inc

Beaver SandraNeutral Tandem Inc

Benedict LarryALDER BIOPHARMACEUTICALS INC

Bennett Mark KCalithera Biosciences, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
TRANS1 INC	Mar 3, 2009	Buy	483	5.90	$2.8K	SEC
TRANS1 INC	Mar 3, 2009	Buy	49,517	5.90	$292.2K	SEC